Immunotherapy For US Patients With Metastatic Cancer at the End of Life—Reply
Kerekes D, Khan S. Immunotherapy For US Patients With Metastatic Cancer at the End of Life—Reply. JAMA Oncology 2024, 10: 1134-1134. PMID: 38842840, DOI: 10.1001/jamaoncol.2024.1566.Peer-Reviewed Original Research
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply